Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
10.1159/000048283 48 LatifS
Safety Information Prescription-only medication
PMID 21459656
Spencer 2011)
Expanding the Role of Semaglutide Under the brand name Wegovy, semaglutide has made its name in obesity care since its initial FDA approval in 2021, with subsequent label expansions including adolescents with obesity in 2022 and for the reduction of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease and obesity or overweight in 2024
FASEB J (2017) 31(1):8595
US$ 25.39
US$ 25.79
US$ 25.46
US$ 20.74
US$ 28.43
US$ 25.89
US$ 22.31
US$ 21.43
US$ 21.02
US$ 28.39
